Not Signed In - MannKind Corporation Completes Patient Enrollment For The Major Phase 3 Safety Study Of Technosphere(R) Insulin In Patients With Diabetes
Fri, 15 Sep 2006 07:00 AM EST
... MannKind Corporation (Nasdaq: MNKD) today announced the completion of patient enrollment in the pivotal long-term safety study of Technosphere(R) Insulin, an investigational inhaled insulin formulation delivered via the Company's proprietary inhaler to patients with diabetes mellitus. [click link for full article] ...
Related Topics
- Insulin
- Insulin Resistance
- Safety (General)
- Diabetes - Type 1
- Gestational Diabetes
- Food Safety
- Insulin glargine
- Drug Safety
- Fire Safety
- Child Safety
- Sports Safety
- Electrical Safety
- Juvenile Diabetes
- Workplace Safety & Health
- Traffic Safety
- Safety
- Diabetes - Type 2
- Patient Issues
- Diabetes Insipidus
- Machine Safety
email this page
print this page
bookmark this page
feedback on this page
